Viroclinics
Viroclinics, officially known as Viroclinics Xplore, is a leading contract research organisation headquartered in the Netherlands. Established in 2008, the company has made significant strides in the fields of virology and infectious diseases, with a focus on preclinical and clinical research services. Viroclinics operates primarily in Europe and North America, providing essential support to pharmaceutical and biotechnology companies. The company offers a unique range of services, including viral challenge studies, immunology assays, and vaccine development, distinguished by its state-of-the-art facilities and expertise in viral pathogens. Viroclinics has positioned itself as a trusted partner in the industry, recognised for its commitment to quality and innovation. With a robust portfolio and a reputation for excellence, Viroclinics continues to play a pivotal role in advancing global health solutions.
DitchCarbon Score
How does Viroclinics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Viroclinics's score of 27 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Viroclinics's reported carbon emissions
In 2022, Viroclinics reported total carbon emissions of approximately 1,024,740,000 kg CO2e, comprising 12,473,000 kg CO2e from Scope 1, 7,577,000 kg CO2e from Scope 2, and a significant 982,740,000 kg CO2e from Scope 3 emissions. This marked an increase from 2021, where total emissions were about 688,284,000 kg CO2e, with Scope 1 emissions at 7,730,000 kg CO2e and Scope 2 at 4,091,000 kg CO2e. Viroclinics has not specified any formal reduction targets or climate pledges, indicating a potential area for future commitment. The company operates within a sector that is increasingly focused on sustainability and reducing carbon footprints, highlighting the importance of establishing clear climate commitments to align with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 7,730,000 | 00,000,000 |
| Scope 2 | 4,091,000 | 0,000,000 |
| Scope 3 | 677,284,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Viroclinics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
